Barron’s Medical Journal Breast Cancer Person Of The Year “Jeanne Rizzo “ & A Cure Report
Barron’s 10th Annual person of the year award for their contribution to breast cancer and A breast cancer cure is Jeanne Rizzo.
Jeanne works for The Breast Cancer Fund and a breast cancer survivor.
Houston – ( AP ) -- Jeanne Rizzo’s vision guided the Breast Cancer Fund to adopt its bold mission to work to prevent breast cancer by eliminating our exposure to toxic chemicals and radiation linked to the disease. Under her direction the organization
has become a national leader in translating the science linking breast cancer and environmental exposures into public education and advocacy campaigns that protect our health and reduce breast cancer risk.
Jeanne Rizzo President/CEO $ 173,580
Jeanne Rizzo’s vision guided the Breast Cancer Fund to adopt its bold mission of working to prevent breast cancer by eliminating exposure to toxic chemicals and radiation linked to the disease. Under her leadership the organization continues its commitment to strong science, smart public policy and consumer education. Ms. Rizzo co-chaired the National Institutes of Health’s Interagency Donald Pliner New Green Bottom Shoes Is The New Shoe Buzz 
Breast Cancer and Environmental Research Coordinating Committee, and is a recipient of the Environmental Protection Agency Region 9 Green Chemistry Environmental Leader Award. She is past chair of the California Breast Cancer Research Program Council and is a steering-committee member of the program’s Prevention Initiative. A nurse, then an award-winning music, theater and film producer, she produced the documentary Climb Against the Odds: Mt. McKinley, which chronicles the Breast Cancer Fund's 1998 expedition.
“when 1 in 8 women will be diagnosed with the disease, how much more awareness do we need? The Breast Cancer Fund is working to shift the conversation from awareness to
prevention. We’re working to stop this disease before it starts, and we need the support of millions of people like you. You can start by pledging to go beyond the pink to prevention. “
In just a generation we’ve witnessed a 40-percent increase in breast cancer, and we know that environmental factors like toxic chemical exposures have played a major role. The Breast Cancer Fund is working to eliminate our exposure to toxic chemicals linked to the disease so that fewer of us, our daughters and increasingly our sons will ever have to hear the words, “You have breast cancer.”
Jeanne leads the organization’s strategic initiatives to remove the chemical bisphenol A, or BPA, from food packaging; to ensure cosmetics are non-toxic; and to overhaul the broken chemicals-management system that allows tens of thousands of toxic and untested chemicals to be used in consumer products. Recent legislative victories include the passage of a federal law banning toxic chemicals linked to breast 
cancer from toys, and California laws creating the first statewide biomonitoring program, advancing the safety of cosmetics and regulating chemicals in consumer products. Recent victories in the marketplace include a commitment from Campbell’s to remove BPA from its can linings and from Johnson & Johnson to globally reformulate its cosmetics products to remove harmful chemicals.
Breast Cancer Report Card Is A ( A ) ----- organizations like The Cancer Genome Atlas has made major advances in breast cancer research. Started in 2006 as a US $100-million pilot, The Cancer Genome Atlas (TCGA) is now the biggest component of the International Cancer 
Genome Consortium, a collaboration of scientists from 16 nations that has discovered nearly 10 million cancer-related mutations.
One of the best Research results is The Cancer Genome Atlas has identified four primary subtypes of breast cancer. Analyses of genomic data have confirmed that there are four primary subtypes of breast cancer, each with its own biology and survival outlooks. These TCGA findings are based on a large number of breast cancer specimens that capture a complete view of the genomic alterations. 
The four groups are called intrinsic subtypes of breast cancer: HER2-enriched (HER2E), Luminal A (LumA), Luminal B (LumB) and Basal-like. A fifth type, called Normal-like, was observed, but because of small numbers (only eight specimens) the researchers were unable to rigorously study it.
According to the World Health Organization, there are approximately 1.3 million new cases of breast cancer and 450,000 deaths worldwide annually. Breast cancer is the most common cancer among women. The majority of cases are sporadic, meaning there is not a family history of breast cancer, as opposed to genetic, where genes predispose a person to the disease.
Genomic Science has given the science community a opportunity to be optimistic about finding a cure. Our 1st Runner up for the person of the year is Dr. Staudt. Genomics is used in so many different ways for an example Dr. Staudt pioneered the use of gene expression profiling to discover molecularly and clinically distinct cancer subtypes and to predict response to therapy. He defined molecular subtypes of lymphoma that were previously unrecognized but are now viewed as distinct diseases that arise from different stages of B cell differentiation, utilize different oncogenic mechanisms and offer new therapeutic targets. 
To develop new treatments for lymphoid malignancies, Staudt’s laboratory uses various high-throughput approaches, including cancer gene resequencing, RNAi/CRISPR-based genetic screens, and combinatorial small molecule screens. The laboratory also conducts genomic investigations within therapeutic trials of targeted agents in lymphoma to define mechanisms of response and resistance.
Through The Cancer Genome Atlas (TCGA) (http://tcga.cancer.gov/), a joint effort of the National Cancer Institute and the National Human Genome Research Institute, we will greatly expand our understanding of the genetic basis of more than 20 cancers that affect adults and identify specific molecular changes that can be targeted for the development of new treatments or exploited to detect cancer earlier or prevent its occurrence.
The Top Rated Cancer Funds if you are looking for a tax deduction here is a list of Award winning organization to donate to says Barron’s Medical Journal
Breast Cancer Fund A-
Breast Cancer Research Foundation A+
Cancer Research Institute A Entertainment Industry Foundation A-
Leukemia and Lymphoma Society B+
LiveStrong Foundation A-
Memorial Sloan-Kettering Cancer Center A
Movember Foundation A
Multiple Myeloma Research Foundation A
National Breast Cancer Coalition Fund A
Ovarian Cancer Research Fund A Prevent Cancer Foundation B+
Prostate Cancer Foundation A
No comments:
Post a Comment